AML with alterations of KMT2A gene (Lysine [K]‐specific methyltransferase 2A, also known as MLL gene), located at 11q23, accounts for 15% to 20% of all childhood leukemias and are of great interest because of their distinct clinical and biological features.3 The gene discussed is KMT2A; the disease is leukemia.